Circulating miR-99a-5p and miR-1246 as Diagnostic and Stage-Associated Biomarkers in Laryngeal Squamous Cell Carcinoma

<b>Background and Objectives</b>: Circulating microRNAs may provide minimally invasive biomarkers for laryngeal squamous cell carcinoma (LSCC), but clinically interpretable data for miR-99a-5p and miR-1246 remain limited. We compared circulating levels of these two miRNAs between LSCC patients and controls and explored stage-associated differences within the cancer cohort. <b>Methods</b>: This single-center case-control study was conducted in Timișoara, Romania. Circulating miRNAs were quantified by RT-qPCR. Expression was summarized as ΔCt [Ct(target) - Ct(miR-16)] and as the relative expression (2<sup>-ΔΔCt</sup>) using the control group as a calibrator. Group comparisons used Mann-Whitney U tests, associations used Spearman correlation, and the diagnostic performance was assessed by ROC analysis and multivariable logistic regression. <b>Results</b>: Fourteen controls were compared with cancer patients with available miRNA measurements (miR-99a-5p, <i>n</i> = 53; miR-1246, <i>n</i> = 49). miR-99a-5p showed significantly higher ΔCt values in cancer patients than in the controls (5.308 [IQR 4.139-6.864] vs. 3.184 [2.142-3.708], <i>p</i> < 0.001), corresponding to a lower relative expression (fold-change 0.200 [0.068-0.449], <i>p</i> < 0.001). miR-1246 did not differ significantly between cancer and controls (<i>p</i> = 0.09). Within the cancer cohort, advanced-stage disease showed a lower relative miR-1246 expression than early-stage disease (ΔCt 5.820 [4.502-6.972] vs. 4.233 [3.109-5.372], <i>p</i> = 0.01; fold-change 0.363 vs. 1.091, <i>p</i> = 0.01), while miR-99a-5p showed a non-significant difference in the same direction (<i>p</i> = 0.052). miR-99a-5p discriminated cancer patients from the controls with an AUC of 0.842 (95% CI 0.744-0.931), sensitivity of 77.4%, and specificity of 92.9% at ΔCt = 4.018. In multivariable analysis, ΔCt(miR-99a-5p) remained independently associated with cancer status (OR 1.89, 95% CI 1.19-3.00; <i>p</i> = 0.007). <b>Conclusions</b>: Circulating miR-99a-5p showed the strongest diagnostic signal in LSCC, whereas miR-1246 appeared more informative for stage-associated biological stratification.

Authors

Institutions

Publication Details

Journal
Biomedicines
Published
2026-03-13
DOI
https://doi.org/10.3390/biomedicines14030659
Primary Topic
MicroRNA in disease regulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Circulating miR-99a-5p and miR-1246 as Diagnostic and Stage-Associated Biomarkers in Laryngeal Squamous Cell Carcinoma

C. Marian, Gheorghe Iovănescu, Nicolae Constantin Balica, Paula Diana Ciordas et al.
Biomedicines
MicroRNA in disease regulation
article

Circulating miR-99a-5p and miR-1246 as Diagnostic and Stage-Associated Biomarkers in Laryngeal Squamous Cell Carcinoma

C. Marian, Gheorghe Iovănescu, Nicolae Constantin Balica, Paula Diana Ciordas, Alexandru-Romulus Hut, Mihail‐Alexandru Badea, ER Boia, Andrada Dumitru, Delia Ioana Horhat
article en

Abstract

<b>Background and Objectives</b>: Circulating microRNAs may provide minimally invasive biomarkers for laryngeal squamous cell carcinoma (LSCC), but clinically interpretable data for miR-99a-5p and miR-1246 remain limited. We compared circulating levels of these two miRNAs between LSCC patients and controls and explored stage-associated differences within the cancer cohort. <b>Methods</b>: This single-center case-control study was conducted in Timișoara, Romania. Circulating miRNAs were quantified by RT-qPCR. Expression was summarized as ΔCt [Ct(target) - Ct(miR-16)] and as the relative expression (2<sup>-ΔΔCt</sup>) using the control group as a calibrator. Group comparisons used Mann-Whitney U tests, associations used Spearman correlation, and the diagnostic performance was assessed by ROC analysis and multivariable logistic regression. <b>Results</b>: Fourteen controls were compared with cancer patients with available miRNA measurements (miR-99a-5p, <i>n</i> = 53; miR-1246, <i>n</i> = 49). miR-99a-5p showed significantly higher ΔCt values in cancer patients than in the controls (5.308 [IQR 4.139-6.864] vs. 3.184 [2.142-3.708], <i>p</i> < 0.001), corresponding to a lower relative expression (fold-change 0.200 [0.068-0.449], <i>p</i> < 0.001). miR-1246 did not differ significantly between cancer and controls (<i>p</i> = 0.09). Within the cancer cohort, advanced-stage disease showed a lower relative miR-1246 expression than early-stage disease (ΔCt 5.820 [4.502-6.972] vs. 4.233 [3.109-5.372], <i>p</i> = 0.01; fold-change 0.363 vs. 1.091, <i>p</i> = 0.01), while miR-99a-5p showed a non-significant difference in the same direction (<i>p</i> = 0.052). miR-99a-5p discriminated cancer patients from the controls with an AUC of 0.842 (95% CI 0.744-0.931), sensitivity of 77.4%, and specificity of 92.9% at ΔCt = 4.018. In multivariable analysis, ΔCt(miR-99a-5p) remained independently associated with cancer status (OR 1.89, 95% CI 1.19-3.00; <i>p</i> = 0.007). <b>Conclusions</b>: Circulating miR-99a-5p showed the strongest diagnostic signal in LSCC, whereas miR-1246 appeared more informative for stage-associated biological stratification.

BiomedicinesVol. 14(3)
Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș (RO), Victor Babeș University of Medicine and Pharmacy Timișoara (RO)
Reduced inequalities
Openalex Percentile: Top 23%
MicroRNA in disease regulation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.